End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.05 USD | +4.64% |
|
+6.18% | +18.75% |
28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
28/06 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
Past dividends on AbbVie Inc.
15/07/2024 | Quarterly 1.55 USD |
12/04/2024 | Quarterly 1.55 USD |
12/01/2024 | Quarterly 1.55 USD |
12/10/2023 | Quarterly 1.48 USD |
13/07/2023 | Quarterly 1.48 USD |
13/04/2023 | Quarterly 1.48 USD |
12/01/2023 | Quarterly 1.48 USD |
13/10/2022 | Quarterly 1.41 USD |
14/07/2022 | Quarterly 1.41 USD |
13/04/2022 | Quarterly 1.41 USD |
13/01/2022 | Quarterly 1.41 USD |
14/10/2021 | Quarterly 1.3 USD |
14/07/2021 | Quarterly 1.3 USD |
14/04/2021 | Quarterly 1.3 USD |
14/01/2021 | Quarterly 1.3 USD |
14/10/2020 | Quarterly 1.18 USD |
14/07/2020 | Quarterly 1.18 USD |
14/04/2020 | Quarterly 1.18 USD |
14/01/2020 | Quarterly 1.18 USD |
11/10/2019 | Quarterly 1.07 USD |
12/07/2019 | Quarterly 1.07 USD |
12/04/2019 | Quarterly 1.07 USD |
14/01/2019 | Quarterly 1.07 USD |
12/10/2018 | Quarterly 0.96 USD |
12/07/2018 | Quarterly 0.96 USD |
12/04/2018 | Quarterly 0.96 USD |
11/01/2018 | Quarterly 0.71 USD |
12/10/2017 | Quarterly 0.64 USD |
12/07/2017 | Quarterly 0.64 USD |
11/04/2017 | Quarterly 0.64 USD |
11/01/2017 | Quarterly 0.64 USD |
12/10/2016 | Quarterly 0.57 USD |
13/07/2016 | Quarterly 0.57 USD |
13/04/2016 | Quarterly 0.57 USD |
13/01/2016 | 0.57 USD |
13/10/2015 | 0.51 USD |
13/07/2015 | 0.51 USD |
13/04/2015 | 0.51 USD |
13/01/2015 | 0.49 USD |
10/10/2014 | 0.42 USD |
11/07/2014 | 0.42 USD |
11/04/2014 | 0.42 USD |
13/01/2014 | 0.4 USD |
10/10/2013 | 0.4 USD |
11/07/2013 | 0.4 USD |
11/04/2013 | 0.4 USD |
11/01/2013 | 0.4 USD |
- Stock Market
- Equities
- ABBV Stock
- ABBVD Stock
- Charts AbbVie Inc.
- Total Return chart